Oct 27, 2022 by James HalleyIs BioNTech a Good Long-Term Buy?BioNTech has a burgeoning oncology portfolio up its sleeve.
Oct 26, 2022 by James Halley3 Medical Stocks On the ReboundAs surgeries bounce back toward pre-pandemic levels, these three companies should benefit.
Oct 26, 2022 by James Halley2 High-Yielding Dividend Stocks Worth the Risk and 1 That Isn'tNot all medical REITs are created equal.
Oct 25, 2022 by James HalleyWhy Bionano Genomics' Shares Spiked 16.42% on TuesdayOn an up day for Wall Street, the genome-mapping company may have benefited from a short squeeze.
Oct 25, 2022 by James HalleyWhy Rite Aid's Shares Jumped 15.3% on TuesdayThe beleaguered drugstore company's shares got a shot in the arm from President Joe Biden.
Oct 25, 2022 by James Halley2 Pharma Stocks With Blockbuster Drugs on the HorizonEli Lilly and Bristol Myers Squibb should benefit from two unique therapies.
Oct 22, 2022 by James HalleyWhy Janux Therapeutics Shares Rose 33.1% This WeekThe clinical-stage biotech company just began its first clinical trial.
Oct 21, 2022 by James HalleyWhy Novavax Stock Rose 12.57% on FridayInvestors did an about-face after the stock slumped earlier in the week.
Oct 21, 2022 by James HalleyWhy Tango Therapeutics Shares Rose 39.7% This WeekThe clinical-stage biotech company has two candidates in its drug pipeline.
Oct 21, 2022 by James Halley3 Alzheimer's Therapy Stocks to Invest inAlzheimer's treatments could make a big winner of these stocks.
Oct 21, 2022 by James Halley2 Reddit Stocks to Buy and Hold for YearsNot all Reddit favorites are risky plays.
Oct 21, 2022 by James HalleyWhy Green Thumb's Rise Could Carry Through 2023The company's planned partnership with Circle K convenience stores in Florida is one of several reasons Green Thumb has a bright future.
Oct 20, 2022 by James Halley3 Stocks to Invest in If Maryland Approves Adult-Use Cannabis SalesPolls show the state's residents are in favor of an adult-use cannabis referendum.
Oct 19, 2022 by James HalleyWhy Insmed's Shares Fell 14.7% on WednesdayThe biotech company is raising money to help it launch another drug, but it's diluting current shareholders in the process.
Oct 19, 2022 by James HalleyBeat the Dow Jones With This Unstoppable Dividend StockThis pharmaceutical stock combines strong financials with an above-average dividend.
Oct 19, 2022 by James HalleyWhich of These Bear Market Growth Stocks Is More Likely to Bounce Back?Both look like bargains, but only one is.
Oct 18, 2022 by James HalleyWhy Legend Biotech's Shares Jumped 14.2% On TuesdayThe company presented news regarding early revenue figures for a multiple myeloma therapy it collaborated on.
Oct 18, 2022 by James Halley2 Top Healthcare Stocks to Buy for the Long HaulThese biotech companies have a long ramp of revenue growth ahead.
Oct 18, 2022 by James HalleyThis Growth Stock Rose Last Week. Is It Still a Buy?Illumina is the dominant player in gene sequencing.
Oct 17, 2022 by James HalleyWhy Inovio Pharmaceuticals' Shares Jumped 17.31% on MondayThe stock jumped Monday despite no news from the company.
